| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | ANTEOTECH LTD: Industry Presentation - AABC USA, Las Vegas | - | ASX | ||
| ANTEOTECH Aktie jetzt für 0€ handeln | |||||
| 28.11. | ANTEOTECH LTD: Change of Director's Interest Notice x 3 | - | ASX | ||
| 28.11. | ANTEOTECH LTD: Notification regarding unquoted securities - ADO | - | ASX | ||
| 28.11. | ANTEOTECH LTD: Notification regarding unquoted securities - ADO | - | ASX | ||
| 26.11. | ANTEOTECH LTD: Results of Meeting | - | ASX | ||
| 25.11. | ANTEOTECH LTD: Managing Director AGM Presentation | - | ASX | ||
| 25.11. | ANTEOTECH LTD: Chair's Address to Shareholders | - | ASX | ||
| 17.11. | Anteotech Hits Key Performance Benchmarks in Testing of Ultranode X High-Silicon Battery | 1 | smallcaps.com.au | ||
| 16.11. | ANTEOTECH LTD: Ultranode X achieves more than 1,000 Cycles at 80% Capacity | - | ASX | ||
| 11.11. | ANTEOTECH LTD: Successful Ultranode scale-up for Wyon Evaluation | - | ASX | ||
| 26.10. | ANTEOTECH LTD: Quarterly Activities/Appendix 4C Cash Flow Report | 7 | ASX | ||
| 23.10. | ANTEOTECH LTD: Notice of General Meeting/Proxy Form | - | ASX | ||
| 23.10. | ANTEOTECH LTD: Notice of Annual General Meeting/Proxy Form | - | ASX | ||
| 17.10. | ANTEOTECH LTD: Notification of cessation of securities - ADO | - | ASX | ||
| 03.10. | ANTEOTECH LTD: 2025 Annual General Meeting date | - | ASX | ||
| 25.09. | ANTEOTECH LTD: Joint Development and Sales Agreement Executed | 2 | ASX | ||
| 28.08. | ANTEOTECH LTD: Cleansing Notice under Section 708A | - | ASX | ||
| 28.08. | ANTEOTECH LTD: Application for quotation of securities - ADO | - | ASX | ||
| 28.08. | ANTEOTECH LTD: Full Year Results and Business Update Presentation | 1 | ASX | ||
| 27.08. | ANTEOTECH LTD: FY2025 Corporate Governance Statement and Appendix 4G | - | ASX |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 23,550 | -0,42 % | EQS-News: Formycon AG: Formycon und Zydus schließen exklusive Lizenz- und Liefervereinbarung für FYB206, ein Biosimilar für Keytruda (Pembrolizumab), in den USA und Kanada | EQS-News: Formycon AG
/ Schlagwort(e): Kooperation/Vereinbarung
Formycon und Zydus schließen exklusive Lizenz- und Liefervereinbarung für FYB206, ein Biosimilar für Keytruda (Pembrolizumab)... ► Artikel lesen | |
| ONTO INNOVATION | 132,00 | -1,49 % | Onto Innovation Inc. (ONTO): A Bull Case Theory | ||
| GAUZY | 1,020 | 0,00 % | Gauzy Ltd. - 6-K, Report of foreign issuer | ||
| SOLESENCE | 2,020 | -2,18 % | Solésence, Inc.: Solésence Reports Third Quarter 2025 Financial Results | Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN)... ► Artikel lesen | |
| KOPIN | 2,130 | -1,39 % | Kopin Corporation: Michael Murray, Kopin's CEO to Present at THEON International's Capital Markets Day (CMD) on November 6, 2025 | Kopin Corporation (NASDAQ: KOPN), a leading provider of application-specific optical systems and high-performance microdisplays for defense, training, enterprise, industrial, consumer and medical... ► Artikel lesen | |
| NANOFOCUS | 1,850 | 0,00 % | HV-Termine: Hauptversammlungen bei bioXXmed, Borussia Dortmund, CureVac, elexxion, Nanofocus, NSI Asset, OTRS | Einmal jährlich müssen sich Aufsichtsrat und Vorstand einer Gesellschaft den Aktionären stellen: Die Hauptversammlung ist das höchste Organ einer Aktiengesellschaft und vergleichbarer Unternehmens-Formen.... ► Artikel lesen | |
| ADVANCE ZINCTEK | 0,525 | -2,78 % | ADVANCE ZINCTEK LIMITED: Response to Television Broadcast Early This Week | ||
| VEECO INSTRUMENTS | 26,200 | 0,00 % | Veeco Instruments Inc.: Veeco Reports Third Quarter 2025 Financial Results | Third Quarter 2025 Highlights: Revenue of $165.9 million, compared with $184.8 million in the same period last yearGAAP net income of $10.6 million, or $0.17 per diluted share, compared with $22.0... ► Artikel lesen | |
| NANOLOGICA | 0,065 | 0,00 % | Nanologica AB: Interim Report Q3 2025 Nanologica AB (publ) | FINANCIAL SUMMARY Net sales for the third quarter amounted to SEK 2,843 thousand (611) and for the nine-month period to SEK 15,930 thousand (7,822)Operating loss for the quarter amounted to SEK -10... ► Artikel lesen | |
| NANOFORM FINLAND | 1,080 | +9,31 % | Nanoform Finland Oyj: Nanoform Q3 report: Momentum in kernels continues, commercial cGMP manufacturing license received, first near-term target for 2026 set | Nanoform Finland Plc | Company Release | November 12, 2025 at 08:10:00 EET
Our product kernels see good momentum. Nanoenzalutamide progresses with the fed arm of the pivotal human study. Licensing and... ► Artikel lesen | |
| NVE | 61,00 | +0,83 % | Dividendenbekanntmachungen (03.11.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADECOAGRO SA LU0584671464 0,1748 USD 0,1515 EUR AMERISERV FINANCIAL INC US03074A1025 0,03 USD 0,026 EUR AON PLC IE00BLP1HW54 0... ► Artikel lesen | |
| GOMSPACE | 1,424 | -3,78 % | GomSpace to provide RF subsystem for Apolink LEO relay demonstrator | ||
| ACACIA RESEARCH | 3,180 | +1,27 % | Acacia Research Non-GAAP EPS of -$0.01 beats by $0.13, revenue of $59.4M beats by $21.4M | ||
| LAMPETIA | 0,068 | 0,00 % | EQS-News: Lampetia AG: Halbjahresfinanzbericht auf neuer Webseite | EQS-News: Lampetia AG
/ Schlagwort(e): Halbjahresbericht
LAMPETIA AG: Halbjahresfinanzbericht auf neuer Webseite
30.09.2025 / 19:51 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen | |
| RIBER | 3,220 | -0,62 % | 2025 first-half earnings: RIBER confirms the rollout of its roadmap and its annual outlook | 2025 first-half earnings: RIBER confirms the rollout of its roadmap and its annual outlook. Half-year revenues and earnings, particularly marked by seasonal activity patterns. Order book of €27.7m... ► Artikel lesen |